These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 3011902)
1. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing. Perl A; Looney RJ; Ryan DH; Abraham GN J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902 [TBL] [Abstract][Full Text] [Related]
2. Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell. Merrill JE; Ullberg M; Jondal M Eur J Immunol; 1981 Jul; 11(7):536-41. PubMed ID: 7286062 [TBL] [Abstract][Full Text] [Related]
3. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells. Bridges KR; Smith BR J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450 [TBL] [Abstract][Full Text] [Related]
4. Activation of cloned human natural killer cells via Fc gamma RIII. Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637 [TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. Koide J; Rivas A; Engleman EG J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816 [TBL] [Abstract][Full Text] [Related]
6. Target structure for natural killer cells: evidence against a unique role for transferrin receptor. Dokhélar MC; Garson D; Testa U; Tursz T Eur J Immunol; 1984 Apr; 14(4):340-4. PubMed ID: 6327320 [TBL] [Abstract][Full Text] [Related]
7. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA; Marlin SD; Schwartz SA; Glorioso JC J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157 [TBL] [Abstract][Full Text] [Related]
8. Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells. Alarcón B; Fresno M J Immunol; 1985 Feb; 134(2):1286-91. PubMed ID: 2981268 [TBL] [Abstract][Full Text] [Related]
9. NK recognition of target structures: is the transferrin receptor the NK target structure? Newman RA; Warner JF; Dennert G J Immunol; 1984 Oct; 133(4):1841-5. PubMed ID: 6206139 [TBL] [Abstract][Full Text] [Related]
10. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198 [TBL] [Abstract][Full Text] [Related]
11. Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway. Ting AT; Einspahr KJ; Abraham RT; Leibson PJ J Immunol; 1991 Nov; 147(9):3122-7. PubMed ID: 1833464 [TBL] [Abstract][Full Text] [Related]
12. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells. Roozemond RC; Bonavida B J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage. Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709 [TBL] [Abstract][Full Text] [Related]
15. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression. Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970 [TBL] [Abstract][Full Text] [Related]
16. Identification of a human natural killer cell target cell antigen with monoclonal antibodies. Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407 [TBL] [Abstract][Full Text] [Related]
17. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. Bolhuis RL; Roozemond RC; van de Griend RJ J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates. Bonavida B; Lebow LT; Bradley TP J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675 [TBL] [Abstract][Full Text] [Related]
19. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. Aramburu J; Balboa MA; Izquierdo M; López-Botet M J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]